Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Safety After Oral Intake: full-pipeline trial registry

2 of 2 indexed Safety After Oral Intake trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Safety After Oral Intake: 2 US clinical trials tracked, 2 recruiting.

Safety After Oral Intake is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of the Pacific, running 1 of these trials.

Enrollment posture brief

Registry condition safety-after-oral-intake

OPEN 2 | RECR 100% | LATE 1 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Safety After Oral Intake (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Safety After Oral Intake

Safety After Oral Intake lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Safety After Oral Intake on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Safety After Oral Intake is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Top Sponsors

Named interventions

Most-linked intervention names on Safety After Oral Intake records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Energy Drink B Dietary supplement
1 trials
Placebo Drink + Placebo Capsule Other
1 trials
Placebo Drink + Caffeine Capsule Dietary supplement
1 trials
Placebo Drink + Moxifloxacin Capsule Drug
1 trials
Energy Drink A + Placebo Capsule Dietary supplement
1 trials
MDI-2517 3600mg Drug
1 trials
MDI-2517 2400mg Drug
1 trials
MDI-2517 1600mg Drug
1 trials

US sites by state

Facility locations filed on Safety After Oral Intake trials. A trial with sites in several states counts in each.

Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Safety After Oral Intake page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Safety After Oral Intake condition card totals 2 registered trials; most-linked intervention Energy Drink B; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.